GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (SHSE:688505) » Definitions » Graham Number

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (SHSE:688505) Graham Number : ¥2.56 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Graham Number?

Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.

As of today (2024-10-31), the stock price of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co is ¥8.70. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's graham number for the quarter that ended in Jun. 2024 was ¥2.56. Therefore, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price to Graham Number ratio for today is 3.99.

The historical rank and industry rank for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Graham Number or its related term are showing as below:

SHSE:688505' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.62   Med: 1.28   Max: 4.25
Current: 0.99

During the past 13 years, the highest Price to Graham Number ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co was 4.25. The lowest was 0.62. And the median was 1.28.

SHSE:688505's Price-to-Graham-Number is ranked better than
78.47% of 576 companies
in the Drug Manufacturers industry
Industry Median: 1.74 vs SHSE:688505: 0.99

Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Graham Number Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Graham Number can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Graham Number Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Graham Number
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.14 2.32 2.76 2.28 1.85

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Graham Number Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.58 2.46 2.19 2.56 -

Competitive Comparison of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Graham Number

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Graham-Number Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Graham-Number distribution charts can be found below:

* The bar in red indicates where Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Graham-Number falls into.



Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Graham Number Calculation

Graham Number is a concept based on Ben Graham's conservative valuation of companies.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Graham Number for the fiscal year that ended in Dec. 2023 is calculated as

Graham Number
=sqrt of (22.5* Tangible Book per Share *EPS without NRI)
=sqrt of (22.5*2.178*0.07)
=1.85

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Graham Number for the quarter that ended in Jun. 2024 is calculated as

Graham Number
=sqrt of (22.5*Tangible Book per Share*EPS without NRI (TTM))
=sqrt of (22.5*2.182*0.097)
=2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co  (SHSE:688505) Graham Number Explanation

Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:

Current price should not be more than 15 times average earnings of the past three years.

Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)

Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.

In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price to Graham number Ratio for today is calculated as

Price to Graham number=Share Price (Today)/Graham number (Q: Jun. 2024 )
=8.70/2.18
=3.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Please keep these in mind:

1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Graham Number Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Graham Number provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
308 Cailun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
Executives
Zhang Wen Bo Core technical personnel
Jiang Jian Ping Core technical personnel
Tao Ji Ning Core technical personnel
Shen Yi Jun Core technical personnel
Li Jun senior management
Xue Yan senior management
Wang Luo Chun Supervisors, core technical personnel
Su Yong Directors, senior managers
Zhao Da Jun Directors, senior managers
Yang Xiao Lin senior management
Gan Yi Min Senior management, core technical personnel
Yu Dai Qing Supervisors

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Headlines

No Headlines